KIA
CLB icon

KLR Investment Advisors’s Core Laboratories CLB Stock Holding History

KLR Investment Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$192K Sell
11,301
-835
-7% -$13.1K 0.14% 181
2023
Q4 		$214K Sell
12,136
-1,224
-9% -$24.7K 0.15% 176
2023
Q3 		$295K Buy
13,360
+371
+3% +$9.11K 0.27% 125
2023
Q2 		$302K Buy
+12,989
New +$294K 0.25% 134

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

KLR Investment Advisors's CLB Position: Q1 2024 in Review

KLR Investment Advisors reduced its Core Laboratories (CLB) stake by 6.9% in Q1 2024, selling an estimated $13.1K and leaving 11,301 shares worth $192K. The position accounts for 0.14% of the portfolio, ranked #181.

KLR Investment Advisors first reported a position in CLB in Q2 2023 and has held it in 4 quarters since. The position peaked at $302K in Q2 2023. 197 funds tracked by Wall St. Rank hold CLB as of Q1 2024.

  • KLR Investment Advisors held 11,301 shares of Core Laboratories worth $192K as of Q1 2024.
  • KLR Investment Advisors sold 835 Core Laboratories shares in Q1 2024, an estimated $13.1K.
  • Core Laboratories made up 0.14% of KLR Investment Advisors's portfolio in Q1 2024, its #181 holding.
  • KLR Investment Advisors first reported a position in Core Laboratories in Q2 2023 and has held it in 4 quarters since.
  • KLR Investment Advisors's Core Laboratories position peaked at $302K in Q2 2023.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.